356 related articles for article (PubMed ID: 7608256)
21. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.
Komminoth P; Kunz E; Hiort O; Schröder S; Matias-Guiu X; Christiansen G; Roth J; Heitz PU
Am J Pathol; 1994 Oct; 145(4):922-9. PubMed ID: 7943181
[TBL] [Abstract][Full Text] [Related]
22. A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma.
Nunes AB; Ezabella MC; Pereira AC; Krieger JE; Toledo SP
J Clin Endocrinol Metab; 2002 Dec; 87(12):5658-61. PubMed ID: 12466368
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas.
Rodien P; Jeunemaitre X; Dumont C; Beldjord C; Plouin PF
Horm Res; 1997; 47(4-6):263-8. PubMed ID: 9167962
[TBL] [Abstract][Full Text] [Related]
24. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
[TBL] [Abstract][Full Text] [Related]
25. "Cold" single-strand conformational variants for mutation analysis of the RET protooncogene.
Musholt PB; Musholt TJ; Goodfellow PJ; Zehnbauer BA; Wells SA; Moley JF
Surgery; 1997 Aug; 122(2):363-70; discussion 370-1. PubMed ID: 9288142
[TBL] [Abstract][Full Text] [Related]
26. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease.
Borst MJ; VanCamp JM; Peacock ML; Decker RA
Surgery; 1995 Apr; 117(4):386-91. PubMed ID: 7716719
[TBL] [Abstract][Full Text] [Related]
28. [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)].
Komminoth P; Muletta-Feurer S; Soltermann A; Gemsenjäger E; Bürgi H; Staub JJ; Schönle E; Fried M; Vetter W; Spinas GA; Heitz PU
Schweiz Med Wochenschr; 1996 Aug; 126(31-32):1329-38. PubMed ID: 8765374
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
Kimura T; Yoshimoto K; Yokogoshi Y; Saito S
Endocr J; 1995 Aug; 42(4):517-25. PubMed ID: 8556059
[TBL] [Abstract][Full Text] [Related]
30. A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.
Tessitore A; Sinisi AA; Pasquali D; Cardone M; Vitale D; Bellastella A; Colantuoni V
J Clin Endocrinol Metab; 1999 Oct; 84(10):3522-7. PubMed ID: 10522989
[TBL] [Abstract][Full Text] [Related]
31. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
32. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
33. Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B.
Kitamura Y; Scavarda N; Wells SA; Jackson CE; Goodfellow PJ
Hum Mol Genet; 1995 Oct; 4(10):1987-8. PubMed ID: 8595427
[No Abstract] [Full Text] [Related]
34. Oncogenic activation of the ret protooncogene in thyroid cancer.
Takahashi M
Crit Rev Oncog; 1995; 6(1):35-46. PubMed ID: 8573606
[TBL] [Abstract][Full Text] [Related]
35. Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
Peacock ML; Borst MJ; Sweet JD; Decker RA
Hum Mutat; 1996; 7(2):100-4. PubMed ID: 8829625
[TBL] [Abstract][Full Text] [Related]
36. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
[TBL] [Abstract][Full Text] [Related]
37. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
[TBL] [Abstract][Full Text] [Related]
38. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
39. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
40. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
